vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»10.35336/VA-2022-4-12vestar-1158Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCASE REPORTSАлгоритмы профилактики и лечения суправентрикулярной тахикардии у пациентов с имплантированными кардиостимуляторами: серия клинических случаевAlgorithms for the prevention and treatment of supraventricular tachycardia in patients with implanted pacemakers: case serieshttps://orcid.org/0000-0003-1871-2754ЛукинИ. Б.LukinI. B.

Лукин Илья Борисович

Тверь, ул. Советская, д. 4.

Lukin Ilya

Tver, 4 Sovetskaya str.

prlukin@gmail.comФедеральное государственное бюджетное образовательное учреждение высшего образования «Тверской государственный медицинский университет» Министерства Здравоохранения Российской ФедерацииРоссияTver State Medical UniversityRussian Federation202208122022294e9-e14Copyright © Лукин И.Б., 20222022Лукин И.Б.Lukin I.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/1158

Представлены 2 клинических случая предупреждения и купирования наджелудочковой тахикардии с использованием современных алгоритмов в электрокардиостимуляторах (ЭКС) последнего поколения у пациентов с брадиаритмиями и пароксизмальной формой фибрилляции предсердий (ФП). В первом клиническом случае у пациента за полгода не наблюдалось ни одного эпизода ФП. Во втором клиническом случае у пациента за 2 года не наблюдалось ни одного эпизода ФП длительностью более 1 минуты. Зафиксированы эпизоды купирования ФП алгоритмами антитахистимуляции. Данные клинические случаи демонстрируют эффективность современных алгоритмов в ЭКС последнего поколения для профилактики и купирования ФП.

Two clinical cases of prevention and relief of supraventricular tachycardia using modern algorithms in pacemakers of the latest generation in patients with bradyarrhythmia and paroxysmal atrial fibrillation (AF) are presented. In the first clinical case, the patient did not have an episode of AF for six months. In the second clinical case, the patient for 2 years did not have an episode of AF lasting more than 1 minute. Episodes sinus rhythm restoration by antitachypacing algorithms were recorded. These clinical cases demonstrate the effectiveness of modern algorithms in pacemakers of the latest generation for the AF prevention and sinus rhythm restoration.

брадикардияфибрилляция предсердийнаджелудочковая тахикардиякардиостимуляторантитахистимуляцииbradycardiaatrial fibrillationsupraventricular tachycardiapacemakerantitachypacingReferencesGillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13(6): 542-7. https://doi.org/10.1046/j.1540-8167.2002.00542.x.Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13(6): 542-7. https://doi.org/10.1046/j.1540-8167.2002.00542.x.Gillis AM. Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol. 2004;10: 55-62. https://doi.org/10.1023/B:JICE.0000011346.32325.b3.Gillis AM. Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol. 2004;10: 55-62. https://doi.org/10.1023/B:JICE.0000011346.32325.b3.Ellenbogen KA. Pacing therapy for prevention of atrial fibrillation. Heart Rhythm. 2007;4: S84-7. https://doi.org/10.1016/j.hrthm.2006.12.005.Ellenbogen KA. Pacing therapy for prevention of atrial fibrillation. Heart Rhythm. 2007;4: S84-7. https://doi.org/10.1016/j.hrthm.2006.12.005.Ricci RP, Boriani G, Grammatico A, et al. Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2006;29: S61-72. https://doi.org/10.1111/j.1540-8159.2006.00484.x.Ricci RP, Boriani G, Grammatico A, et al. Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2006;29: S61-72. https://doi.org/10.1111/j.1540-8159.2006.00484.x.Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22: 983-988. https://doi.org/10.1161/01.str.22.8.983.Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22: 983-988. https://doi.org/10.1161/01.str.22.8.983.Benjamin EJ, Wolf PA, D’Agostino RB. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98: 946-952. https://doi.org/10.1161/01.cir.98.10.946.Benjamin EJ, Wolf PA, D’Agostino RB. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98: 946-952. https://doi.org/10.1161/01.cir.98.10.946.Wyse DG, Waldo AL, DiMarco JP et al. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347: 1825-1833. https://doi.org/10.1056/NEJMoa021328.Wyse DG, Waldo AL, DiMarco JP et al. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347: 1825-1833. https://doi.org/10.1056/NEJMoa021328.Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347: 1834-1840. https://doi.org/10.1056/NEJMoa021375.Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347: 1834-1840. https://doi.org/10.1056/NEJMoa021375.Capucci A, Groppi F, Ruiter J, et al, on behalf of the AF Therapy Study Group. Evaluation of re-initiation of atrial fibrillation through a pacemaker with focused diagnostics. Pacing Clin Electrophysiol. 2000;23: 722.Capucci A, Groppi F, Ruiter J, et al, on behalf of the AF Therapy Study Group. Evaluation of re-initiation of atrial fibrillation through a pacemaker with focused diagnostics. Pacing Clin Electrophysiol. 2000;23: 722.Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2021;42(5): 373-498 https://doi.org/10.1093/eurheartj/ehaa612.Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2021;42(5): 373-498 https://doi.org/10.1093/eurheartj/ehaa612.Israel CW, Hügl B, Unterberg D, et al., on behalf of the AT500 Verification Study. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol. 2001;12: 1121-8. https://doi.org/10.1046/j.1540-8167.2001.01121.x.Israel CW, Hügl B, Unterberg D, et al., on behalf of the AT500 Verification Study. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol. 2001;12: 1121-8. https://doi.org/10.1046/j.1540-8167.2001.01121.x.Lee MA, Weachter R, Pollak S, et al. for the ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized Figure 3 Graph showing incorrect sensing in each study phase. 796 N. Sulke et al. trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol. 2003; 4;41(11): 1926-32. https://doi.org/10.1016/s0735-1097(03)00426-1.Lee MA, Weachter R, Pollak S, et al. for the ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized Figure 3 Graph showing incorrect sensing in each study phase. 796 N. Sulke et al. trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol. 2003; 4;41(11): 1926-32. https://doi.org/10.1016/s0735-1097(03)00426-1.Padeletti L, Pürerfellner H, Adler SW, et al. for the Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol. 2003;14: 1189-95. https://doi.org/10.1046/j.1540-8167.2003.03191.x.Padeletti L, Pürerfellner H, Adler SW, et al. for the Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol. 2003;14: 1189-95. https://doi.org/10.1046/j.1540-8167.2003.03191.x.Carlson MD, Ip J, Messenger J, et al. for the ADOPT Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation. results of the dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol. 2003;42: 627-33. https://doi.org/10.1016/s0735-1097(03)00780-0.Carlson MD, Ip J, Messenger J, et al. for the ADOPT Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation. results of the dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol. 2003;42: 627-33. https://doi.org/10.1016/s0735-1097(03)00780-0.Wiberg S, Lonnerholm S, Jensen SM, et al. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study. PACE. 2003;26: 1841-8. https://doi.org/10.1046/j.1460-9592.2003.t01-1-00278.x.Wiberg S, Lonnerholm S, Jensen SM, et al. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study. PACE. 2003;26: 1841-8. https://doi.org/10.1046/j.1460-9592.2003.t01-1-00278.x.Padeletti L, Pürerfellner H, Mont L, et al. New-generation atrial antitachycardia pacing (ReactiveATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Heart Rhythm. 2015;12(8): 1717-1725. https://doi. org/10.1016/j.hrthm.2015.04.015.Padeletti L, Pürerfellner H, Mont L, et al. New-generation atrial antitachycardia pacing (ReactiveATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Heart Rhythm. 2015;12(8): 1717-1725. https://doi. org/10.1016/j.hrthm.2015.04.015.Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart Journal. 2021; 42 (35): 3427-3520 https://doi.org/10.1093/eurheartj/ehab364.Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart Journal. 2021; 42 (35): 3427-3520 https://doi.org/10.1093/eurheartj/ehab364.Boriani G, Padeletti L, Santini M, et al. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol. 2005;16(7): 714-23. https://doi.org/10.1111/j.1540-8167.2005.40716.x.Boriani G, Padeletti L, Santini M, et al. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol. 2005;16(7): 714-23. https://doi.org/10.1111/j.1540-8167.2005.40716.x.

The authors declare that there are no conflicts of interest present.